PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable device.

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with ...

The European Commission (EC) will restrict Chinese firms from EU government purchases of medical devices exceeding €5m ($5.7m ...

The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...

GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the PET/CT ...

Qiagen, Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...

GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, ...

ClearNote Health has commenced subject enrolment in a multicentre, prospective study involving its Avantect pancreatic cancer ...

Grail has reported encouraging top-line performance and safety outcomes from its registrational PATHFINDER 2 study’s ...

Penumbra has completed subject enrolment in the multi-centre, randomised controlled trial, STORM-PE, for pulmonary embolism ...

Visby Medical has secured around $55m in its funding round to expedite the launch and distribution of its at-home Women's ...